Posted 12th October 2018 by Laura Berry
Having a powerful set of tools is essential in life science research so we’ve compiled the best free platforms for genetic engineers, molecular and synthetic biologists.
Posted 23rd May 2018 by Kieran Chambers
An increasing number of people are being diagnosed with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year, and the primary method of treatment is weight loss. With no approved medicines on the market, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood, and definitive diagnostic methods are invasive, so development has been slow.
Over the course of the Global NASH Congress, 40 expert-led presentations and interactive roundtable discussions explored these key issues. If you were unable to attend, please enjoy these free slides from Eric Hughes, Jon Reik and Pierre Bedossa.
Posted 11th August 2017 by Laura Berry
2013 saw a dramatic increase in synthetic biology investment: a trend which continues year-on-year. In 2016 there were 8x more investments than in 2005 and having already surpassed 2016’s numbers, 2017 is set to be the biggest yet.
Posted 14th July 2017 by Laura Berry
A critical point in any field of research is that of commercialisation; when research builds to the point that the dam bursts, bottlenecks open and opportunities are ripe. 2016 saw the largest peak in microbiome investment since 2012 when the CRISPR-Cas9 ‘instructions’ were published.
Posted 18th January 2017 by Laura Berry
Chronic illnesses such as IBD, obesity and diabetes were once considered ‘western’ diseases. However, changes to diet and lifestyle are steadily taking their toll and prevalence rates are rising across the globe. (1)
Posted 10th October 2016 by Laura Berry
Finding the information that you need on plant genomes is difficult when published data is spread across a vast amount of journals and the rest is unpublished. So we gathered together 10 of the best plant genome databases to make your job easier.